Literature DB >> 25732572

Association of positively selected eIF3a polymorphisms with toxicity of platinum-based chemotherapy in NSCLC patients.

Ji-ye Yin1, Xiang-guang Meng2, Chen-yue Qian1, Xiang-ping Li3, Juan Chen1, Yi Zheng1, Rong Liu1, Hong-hao Zhou1, Zhao-qian Liu1.   

Abstract

AIM: Eukaryotic translation initiation factor 3 subunit A (eIF3a) plays critical roles in regulating the initiation of protein translation, and eIF3a is highly expressed in lung cancer. In this study, we investigated the association of the positively selected SNPs of eIF3a with the response to and toxicity of platinum-based chemotherapy in Chinese patients with non-small cell lung cancer (NSCLC).
METHODS: SNP data for eIF3a locus were downloaded from HapMap database. For each SNP, haplotype, LD profile and population differentiation were analyzed. The long-range haplotype (LRH) test was employed to identify positively selected SNPs of eIF3a. A total of 325 NSCLC patients were enrolled and genotyped for these SNPs.
RESULTS: Five positively selected (rs1409314, rs4752219, rs4752220, rs7091672 and rs10510050) and 5 non-positively selected SNPs (rs10886342, rs11198804, rs2275112, rs10787899 and rs4752269) were identified in the LRH test. However, none of them was correlated with the platinum-based chemotherapy response. In contrast, 4 of the positively selected SNPs (rs1409314, rs4752219, rs4752220 and rs7091672) were significantly correlated with the toxicities tested (neutropenia, anemia, thrombocytopenia, emesis and hepatotoxicity). In addition, rs10510050 was significantly correlated with thrombocytopenia, emesis and hepatotoxicity. None of the 5 non-positively selected SNPs was correlated with the 5 toxicities.
CONCLUSION: The positively selected SNPs of eIF3a are significantly correlated with platinum-based chemotherapy toxicities in Chinese NSCLC patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25732572      PMCID: PMC4349930          DOI: 10.1038/aps.2014.160

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  29 in total

1.  Genetic structure of human populations.

Authors:  Noah A Rosenberg; Jonathan K Pritchard; James L Weber; Howard M Cann; Kenneth K Kidd; Lev A Zhivotovsky; Marcus W Feldman
Journal:  Science       Date:  2002-12-20       Impact factor: 47.728

Review 2.  Genomic insights into positive selection.

Authors:  Shameek Biswas; Joshua M Akey
Journal:  Trends Genet       Date:  2006-06-30       Impact factor: 11.639

3.  The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients.

Authors:  Xiang-Ping Li; Ji-Ye Yin; Ying Wang; Hui He; Xi Li; Wei-Jing Gong; Juan Chen; Chen-Yue Qian; Yi Zheng; Fang Li; Tao Yin; Zhi-Cheng Gong; Bo-Ting Zhou; Yu Zhang; Ling Xiao; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Tumour Biol       Date:  2014-05-23

4.  Functional analysis of the interaction between HCV 5'UTR and putative subunits of eukaryotic translation initiation factor eIF3.

Authors:  E Buratti; S Tisminetzky; M Zotti; F E Baralle
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

5.  Association between eIF3α polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients.

Authors:  Xiaojing Xu; Lifang Han; Li Duan; Yingchun Zhao; Huaping Yang; Boting Zhou; Rui Ma; Ruixia Yuan; Honghao Zhou; Zhaoqian Liu
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

6.  Annotation: the analysis of variance and the analysis of causes.

Authors:  R C Lewontin
Journal:  Am J Hum Genet       Date:  1974-05       Impact factor: 11.025

Review 7.  Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer.

Authors:  Zizheng Dong; Jian-Ting Zhang
Journal:  Crit Rev Oncol Hematol       Date:  2006-07-07       Impact factor: 6.312

8.  Biochemical characterization of mammalian translation initiation factor 3 (eIF3). Molecular cloning reveals that p110 subunit is the mammalian homologue of Saccharomyces cerevisiae protein Prt1.

Authors:  J Chaudhuri; A Chakrabarti; U Maitra
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

9.  Signatures of recent positive selection at the ATP-binding cassette drug transporter superfamily gene loci.

Authors:  Zihua Wang; Jingbo Wang; Erwin Tantoso; Baoshuang Wang; Amy Y P Tai; London L P J Ooi; Samuel S Chong; Caroline G L Lee
Journal:  Hum Mol Genet       Date:  2007-04-05       Impact factor: 6.150

10.  Identification of a 170-kDa protein over-expressed in lung cancers.

Authors:  R Pincheira; Q Chen; J T Zhang
Journal:  Br J Cancer       Date:  2001-06-01       Impact factor: 7.640

View more
  8 in total

Review 1.  Single nucleotide polymorphisms in piRNA-pathway genes: an insight into genetic determinants of human diseases.

Authors:  Jyoti Roy; Kalyani Anand; Swati Mohapatra; Rojalin Nayak; Trisha Chattopadhyay; Bibekanand Mallick
Journal:  Mol Genet Genomics       Date:  2019-10-14       Impact factor: 3.291

2.  Gene-gene and gene-environment interactions influence platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.

Authors:  Jia-Jia Cui; Lei-Yun Wang; Tao Zhu; Wei-Jing Gong; Hong-Hao Zhou; Zhao-Qian Liu; Ji-Ye Yin
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

3.  Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.

Authors:  Chen-Yue Qian; Yi Zheng; Ying Wang; Juan Chen; Jun-Yan Liu; Hong-Hao Zhou; Ji-Ye Yin; Zhao-Qian Liu
Journal:  Chin J Cancer       Date:  2016-09-02

4.  Association between DNA mismatch repair gene polymorphisms and platinum-based chemotherapy toxicity in non-small cell lung cancer patients.

Authors:  Jun-Yan Liu; Chen-Yue Qian; Yuan-Feng Gao; Juan Chen; Hong-Hao Zhou; Ji-Ye Yin
Journal:  Chin J Cancer       Date:  2017-01-16

5.  Gene-gene and gene-environment interaction data for platinum-based chemotherapy in non-small cell lung cancer.

Authors:  Lei-Yun Wang; Jia-Jia Cui; Jun-Yan Liu; Ao-Xiang Guo; Zhen-Yu Zhao; Ying-Zi Liu; Ji-Chu Wu; Min Li; Cheng-Ping Hu; Yang Gao; Hong-Hao Zhou; Ji-Ye Yin
Journal:  Sci Data       Date:  2018-12-11       Impact factor: 6.444

6.  Circular RNA screening from EIF3a in lung cancer.

Authors:  Ma-Sha Huang; Fu-Qiang Yuan; Yang Gao; Jun-Yan Liu; Yi-Xin Chen; Chen-Jing Wang; Bai-Mei He; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Cancer Med       Date:  2019-06-13       Impact factor: 4.452

7.  A systematic review and network meta-analysis of single nucleotide polymorphisms associated with pancreatic cancer risk.

Authors:  Zhuo-Miao Ye; Li-Juan Li; Ming-Bo Luo; Hong-Yuan Qing; Jing-Hui Zheng; Chi Zhang; Yun-Xin Lu; You-Ming Tang
Journal:  Aging (Albany NY)       Date:  2020-11-20       Impact factor: 5.682

8.  eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation.

Authors:  Yu Zhang; Jing-Jing Yu; Yan Tian; Zheng-Zheng Li; Cai-Yi Zhang; Shu-Fen Zhang; Lan-Qin Cao; Yi Zhang; Chen-Yue Qian; Wei Zhang; Hong-Hao Zhou; Ji-Ye Yin; Zhao-Qian Liu
Journal:  Oncotarget       Date:  2015-09-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.